Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604)

Ítems similars

• A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)
  per: Huddart, Robert A., et al.
  Publicat: (2015)
• Treatment of metastatic testicular tumours with bleomycin, etoposide, cisplatin and vincristine (BEPV).
  per: Price, B A, et al.
  Publicat: (1992)
• Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours
  per: Anthoney, D A, et al.
  Publicat: (2004)
• The Effects of Chemotherapeutic Agents, Bleomycin, Etoposide, and Cisplatin, on Chromatin Remodeling in Male Rat Germ Cells
  per: Bagheri-Sereshki, Negar, et al.
  Publicat: (2016)
• The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis [Image: see text] ()
  per: Cullen, Michael, et al.
  Publicat: (2020)